DK1051155T3 - Nasale opløsninger - Google Patents

Nasale opløsninger

Info

Publication number
DK1051155T3
DK1051155T3 DK99904823T DK99904823T DK1051155T3 DK 1051155 T3 DK1051155 T3 DK 1051155T3 DK 99904823 T DK99904823 T DK 99904823T DK 99904823 T DK99904823 T DK 99904823T DK 1051155 T3 DK1051155 T3 DK 1051155T3
Authority
DK
Denmark
Prior art keywords
nasal solutions
liquid
nasal
inter alia
relates
Prior art date
Application number
DK99904823T
Other languages
English (en)
Inventor
Christopher Buckley
Matthias Seidel
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Application granted granted Critical
Publication of DK1051155T3 publication Critical patent/DK1051155T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DK99904823T 1998-01-30 1999-01-28 Nasale opløsninger DK1051155T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810069 1998-01-30
PCT/EP1999/000555 WO1999038492A1 (en) 1998-01-30 1999-01-28 Nasal solutions

Publications (1)

Publication Number Publication Date
DK1051155T3 true DK1051155T3 (da) 2002-09-16

Family

ID=8235913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99904823T DK1051155T3 (da) 1998-01-30 1999-01-28 Nasale opløsninger

Country Status (12)

Country Link
EP (1) EP1051155B1 (da)
JP (1) JP4603687B2 (da)
AT (1) ATE219657T1 (da)
AU (1) AU741364B2 (da)
CA (1) CA2311530C (da)
DE (1) DE69901936T2 (da)
DK (1) DK1051155T3 (da)
ES (1) ES2180274T3 (da)
IL (1) IL136591A (da)
NZ (1) NZ505919A (da)
PT (1) PT1051155E (da)
WO (1) WO1999038492A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
EA003329B1 (ru) * 1999-06-22 2003-04-24 Бёрингер Ингельхайм Интернациональ Гмбх Стабильный раствор ксилометазолина и оксиметазолина
PL208686B1 (pl) * 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
BG65734B1 (bg) * 2002-02-22 2009-09-30 Био Терапютикс - Еоод Течен мукоадхезивен фармацевтичен състав
EP1517673A1 (en) * 2002-06-20 2005-03-30 Novartis Consumer Health S.A. Nasal composition comprising a mucopolysaccharide and propylene glycol
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
BRPI0412029A (pt) 2003-06-30 2006-09-05 Alza Corp formulações para microprojeções revestidas contendo contra-ìons não-voláteis
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
JP4956981B2 (ja) * 2005-01-05 2012-06-20 大正製薬株式会社 オキシメタゾリン含有水性組成物
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US8940796B2 (en) * 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
DE102008007198A1 (de) * 2008-02-01 2009-08-13 Infectopharm Arzneimittel Und Consilium Gmbh Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
JP2012505236A (ja) * 2008-10-10 2012-03-01 シェーリング コーポレイション コルチコステロイド組成物およびそれの治療方法
DE202013000748U1 (de) 2013-01-24 2013-02-19 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
DE102013001151A1 (de) 2013-01-24 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
PL2759290T3 (pl) 2013-01-24 2020-03-31 Merz Pharma Gmbh & Co. Kgaa Płynny preparat w aerozolu do stosowania donosowego z wydłużonym miejscowym czasem działania
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
JP6039861B2 (ja) * 2013-07-17 2016-12-07 ダウ グローバル テクノロジーズ エルエルシー ヒドロキシアルキルメチルセルロースを含む粘膜適用組成物
US20160228559A1 (en) * 2013-09-25 2016-08-11 Dow Global Technologies Llc Composition for application to a mucosa comprising a cellulose ether
PL3236933T3 (pl) * 2014-12-24 2019-05-31 Jadran Galenski Laboratorij D D Kompozycja do podawania donosowego zawierająca wodę morską jako zaróbkę poprawiającą trwałość
JOP20190241B1 (ar) * 2017-04-17 2023-09-17 Hikma Pharmaceuticals Usa Inc مستحضرات رذاذ إبينيفرين
WO2019241401A1 (en) * 2018-06-13 2019-12-19 Insys Development Company, Inc. Epinephrine spray formulations
HRP20211996T1 (hr) 2018-09-11 2022-04-01 Lead Biotherapeutics Ltd. Sustav mukoadhezivne disperzijske nanočestice i metoda proizvodnje istog

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH04327533A (ja) * 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
DE69222295T2 (de) * 1992-05-26 1998-04-09 Procter & Gamble Pulverförmige pharmazeutische Zusammensetzung
CA2101126A1 (en) * 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
ATE241984T1 (de) * 1993-03-26 2003-06-15 Franciscus Wilhelmus He Merkus Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
JPH07109228A (ja) * 1993-10-08 1995-04-25 Earth Chem Corp Ltd リゾチーム配合口腔用組成物
EP0689843B1 (en) * 1993-12-17 2003-09-10 Mochida Pharmaceutical Co., Ltd. Composition containing soluble thrombomodulins
JP3269770B2 (ja) * 1995-03-02 2002-04-02 参天製薬株式会社 再分散性の優れたイオン性高分子配合水性懸濁点眼剤
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
EP1020194A4 (en) * 1997-10-01 2003-05-21 Wakamoto Pharma Co Ltd OIL / WATER EMULSION COMPILATIONS

Also Published As

Publication number Publication date
EP1051155B1 (en) 2002-06-26
AU2519899A (en) 1999-08-16
DE69901936T2 (de) 2002-11-28
ES2180274T3 (es) 2003-02-01
AU741364B2 (en) 2001-11-29
WO1999038492A1 (en) 1999-08-05
IL136591A0 (en) 2001-06-14
JP2002501884A (ja) 2002-01-22
PT1051155E (pt) 2002-10-31
ATE219657T1 (de) 2002-07-15
CA2311530C (en) 2008-06-10
JP4603687B2 (ja) 2010-12-22
NZ505919A (en) 2002-10-25
IL136591A (en) 2005-08-31
EP1051155A1 (en) 2000-11-15
CA2311530A1 (en) 1999-08-05
DE69901936D1 (de) 2002-08-01

Similar Documents

Publication Publication Date Title
DE69901936T2 (de) Nasale lösungen
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
ES2162951T3 (es) Estabilizacion de composiciones de prostaglandina.
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
SE0001899D0 (sv) New compounds
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
TR199901411T2 (xx) Analjezik etkili yeni bile�imler.
DE60108236D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
BR0109943A (pt) Composições farmacêuticas
AU3227700A (en) Skin sanitizing compositions
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
SE9801494D0 (sv) Novel use
BR0105563A (pt) Derivados e análogos de galantamina
DE69911388D1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DK1092431T3 (da) Lasofoxifenpræparater
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DK0977871T3 (da) Neurotrypsin
ATE241640T1 (de) Fusidinsäure-derivate
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
MXPA03010821A (es) Composiciones de aroma y fragancias.
TR200001466T2 (tr) Burun solüsyonları
DE60212101D1 (de) Alanin-2,6-dialkoxyphenylesterderivate als hypnotika
BR0211522A (pt) Tratamento de dor crÈnica com 3-arilóxi-3-fenilpropanaminas